Under current Health Canada regulations (GUI-0100), peptides and SARMs are not approved for human use. They may only be acquired and possessed for purposes such as laboratory research, chemical analysis, and in-vitro testing by qualified research organizations.

Peptide sequences are prone to enzymatic degradation and can denature when exposed to heat. To maintain stability, lyophilized (freeze-dried) powders should be stored at -20 °C for long-term preservation, while reconstituted solutions should be kept between 2–8 °C to minimize molecular degradation.